2m 2m 2m 2m 2m 2m 2m
KALARIS THERAP (KLRS)
NASDAQ
$1.98-$0.04 (-1.98%)
Price as of Oct 22, 2026 7:30 PM EDT- $48.1MMarket Cap
- -53.88%1-Year Change
- BiotechnologyIndustry
KALARIS THERAP (KLRS)
$1.98-$0.04 (-1.98%)
KLRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.02 | ||
Change | -$0.05 (-2.42%) | ||
Open | $2.00 | ||
High | $2.18 | ||
Low | $1.95 | ||
Previous Close | $2.07 | ||
Volume | 84,354 | ||
30-Day Average Volume | 83,699 | ||
1-Week Change | -5.16% | ||
1-Month Change | -37.75% | ||
1-Year Change | -53.88% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 23.8M | ||
Total Assets | $99.5M | ||
Market Cap | $48.1M | ||
Enterprise Value | $4.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$11.5M | ||
Free Cash Flow | -$11.0M | ||
EBIT | -$11.5M | ||
EBITDA | -$11.5M | ||
Net Working Capital | $87.2M | ||
EPS | -$0.48 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | 1 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue